Targeting ELOVL6 to disrupt c-MYC driven lipid metabolism in pancreatic cancer enhances chemosensitivity. - García García A; Ferrer Aporta M; Vallejo Palma G; Giráldez Trujillo A; Castillo-González R; Calzón Lozano D; Mora Perdiguero A; Muñoz Velasco R; Colina Castro M; de Simone Benito E; Torres-Ruiz R; Rodriguez-Perales S; et al. (Nature communications, 2025)